These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23973042)

  • 61. Finally: the proof of concept--from animal studies, imaging and the clinical evidence of plaque rupture.
    Moriguchi E
    Atherosclerosis; 2010 Dec; 213(2):367-8. PubMed ID: 20970136
    [No Abstract]   [Full Text] [Related]  

  • 62. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization.
    Libby P
    Am J Cardiol; 2000 Oct; 86(8B):3J-8J; discussion 8J-9J. PubMed ID: 11081443
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-inflammatory therapies for cardiovascular disease.
    Ridker PM; Lüscher TF
    Eur Heart J; 2014 Jul; 35(27):1782-91. PubMed ID: 24864079
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Colchicine Use in Acute Coronary Syndromes: An Update.
    Tapoi L; Benchea L; Siriopol D; Kanbay M; Covic A
    Angiology; 2021 Jul; 72(6):503-510. PubMed ID: 33412929
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colchicine for the treatment of coronary artery disease.
    Aimo A; Pascual-Figal DA; Barison A; Cediel G; Vicente ÁH; Saccaro LF; Emdin M; Bayes-Genis A
    Trends Cardiovasc Med; 2021 Nov; 31(8):497-504. PubMed ID: 33096241
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?
    Lorenzatti AJ; Retzlaff BM
    Int J Cardiol; 2016 Oct; 221():581-6. PubMed ID: 27420583
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
    Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
    Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inflammation as a Therapeutic Target in Atherosclerosis.
    Nguyen MT; Fernando S; Schwarz N; Tan JT; Bursill CA; Psaltis PJ
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31357404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Atherothrombosis : Novel therapeutic strategies].
    Soehnlein O
    Herz; 2018 Mar; 43(2):103-108. PubMed ID: 29236146
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vulnerable plaque and inflammation: potential clinical strategies.
    Drakopoulou M; Toutouzas K; Michelongona A; Tousoulis D; Stefanadis C
    Curr Pharm Des; 2011 Dec; 17(37):4190-209. PubMed ID: 22204378
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-inflammatory approaches to ischaemic stroke prevention.
    Kelly PJ; Murphy S; Coveney S; Purroy F; Lemmens R; Tsivgoulis G; Price C
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):211-218. PubMed ID: 28935831
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Strategies to achieve coronary arterial plaque stabilization.
    Rabbani R; Topol EJ
    Cardiovasc Res; 1999 Feb; 41(2):402-17. PubMed ID: 10341840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
    Banach M; Penson PE
    Curr Atheroscler Rep; 2021 May; 23(7):32. PubMed ID: 33970350
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advances in the understanding of plaque composition and treatment options: year in review.
    Tomey MI; Narula J; Kovacic JC
    J Am Coll Cardiol; 2014 Apr; 63(16):1604-16. PubMed ID: 24583311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic inhibition of MPO stabilizes pre-existing high risk atherosclerotic plaque.
    Chen W; Tumanov S; Kong SMY; Cheng D; Michaëlsson E; Bongers A; Power C; Ayer A; Stocker R
    Redox Biol; 2022 Dec; 58():102532. PubMed ID: 36375379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Inflammatory processes in the pathogenesis of acute coronary syndromes].
    Lach D; Cichon N; Dziedzic A; Bijak M; Saluk J
    Pol Merkur Lekarski; 2017 May; 42(251):183-186. PubMed ID: 28557963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Colchicine: an affordable anti-inflammatory agent for atherosclerosis.
    Thompson PL; Nidorf SM
    Curr Opin Lipidol; 2018 Dec; 29(6):467-473. PubMed ID: 30320614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Requiem for the 'vulnerable plaque'.
    Libby P; Pasterkamp G
    Eur Heart J; 2015 Nov; 36(43):2984-7. PubMed ID: 26206212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.